Germline BLM mutations and metastatic prostate cancer

Keyphrases

• Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 100%
• Germ Cells 100%
• Biallelic 60%
• Germline mutation 60%
• GnomAD 60%
• Loss Function 40%
• Prostate Cancer Patients 40%
• BRCA2 40%
• Relative Risk 40%
• Control Population 40%
• BRCA2 mutation 40%
• DNA Sequencing 20%
• In Cancer 20%
• Tumor 20%
• High Risk 20%
• Genetic Disease 20%
• Advanced Prostate Cancer 20%
• Routine Care 20%
• Chromosomal Instability 20%
• Somatic mutation 20%
• Somatic Alterations 20%
• Protein Functionality 20%
• Tumor Tissue 20%
• Heterozygote 20%
• Sister Chromatid Exchange 20%
• Bloom Syndrome 20%
• Population Sample 20%
• Cancer Susceptibility 20%
• Academic Center 20%
• Control Information 20%
• Multiple Cancers 20%
• Tumor DNA 20%
• Pathogenic mutations 20%
• Growth Deficiency 20%
• Germline Genetic Testing 20%
• Tumor Sequencing 20%

Biochemistry, Genetics and Molecular Biology

• Germline 100%
• Germ Cell 100%
• BRCA2 66%
• Germline Mutation 50%
• Population Dynamics 33%
• Prevalence 33%
• Chromosome Instability 16%
• Genetic Disorder 16%
• Bloom Syndrome 16%
• DNA Sequence 16%
• Somatic Mutation 16%
• Genetic Screening 16%
• Sister Chromatid Exchange 16%
• Photosensitivity 16%